✦ LIBER ✦

The darker side of Ca2+ signaling by neuronal Ca2+-sensor proteins: from Alzheimer's disease to cancer

✍ Scribed by Karl-Heinz Braunewell

Book ID: 116918528
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 260 KB
Volume: 26
Category: Article
ISSN: 0165-6147
DOI: 10.1016/j.tips.2005.04.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Ability of Amyloid β-Protein [AβP (1

The Ability of Amyloid β-Protein [AβP (1–40)] to Form Ca2+ Channels Provides a Mechanism for Neuronal Death in Alzheimer's Disease

✍ NELSON ARISPE; HARVEY B. POLLARD; EDUARDO ROJAS 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 530 KB

Phosphorylation of tau protein to sites

Phosphorylation of tau protein to sites found in Alzheimer's disease brain is catalyzed by Ca2+/calmodulin-dependent protein kinase II as demonstrated tandem mass spectrometry

✍ Yoshiyuki Yoshimura; Tatsuya Ichinose; Takashi Yamauchi 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Exaggerated [Ca2+]I Signaling and Alzhei

Exaggerated [Ca2+]I Signaling and Alzheimer's Disease-Like Phenotypes of PS1M146V Mice are Attenuated by Decreasing Brain InsP3R-1 Protein Levels

✍ Shilling, Dustin; Muller, Marioly; Takano, Hajime; Mak, Don-On D.; Abel, Ted; Co 📂 Article 📅 2013 🏛 Biophysical Society 🌐 English ⚖ 40 KB

Processing progress in Alzheimer's disea

Processing progress in Alzheimer's disease : Inhibition of amyloid β-protein production in neural cells by the protease inhibitor AEBSF Citron, M. et al. (1996) Neuron 17, 171–179 Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the preselinin 1 nad 2 and APP mutations linked to familial Alzheimer's disease Scheuner, D. et al. (1996) Nat. Med. 2, 864–870

✍ B.Joy Snider 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 328 KB

Commentary on “The E3 ubiquitin ligase S

Commentary on “The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity.” Qi J, Tripathi M, Mishra R, Sahgal N, Fazli L, Ettinger S, Placzek WJ, Claps G, Chung LW, Bowtell D, Gleave M, Bhowmick N, Ronai ZA, Signal Transduction Program, Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA, USA.

✍ Olumi, Aria F. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Books of Interest Emerging Drugs and Tar

Books of Interest Emerging Drugs and Targets for Alzheimer’s Disease. Volume 1: Beta-Amyloid, Tau Protein and Glucose Metabolism . Edited by Ana Martinez Royal Society of Chemistry , Cambridge, U.K. 2010 . xxiv + 317 pp. 16 × 24 cm. ISBN 978-1-84973-063-1 . $249.00. Emerging Drugs and Targets for Alzheimer’s Disease. Volume 2: Neuronal Plasticity, Neuronal Protection and Other Miscellaneous Strategies . Edited by Ana Martinez Royal Society of Chemistry , Cambridge, U.K. 2010 . xxiv + 301 pp. 16 × 24 cm. ISBN 978-1-84973-064-8 . $249.00. Biopharmaceuticals in Plants. Toward the Next Century of Medicine . By Kathleen Laura Hefferon CRC Press , Boca Raton, FL . 2010 . xvii + 206 pp. 16 × 24 cm. ISBN 13 978-1-4398-0474-2 . $99.95. GPCR Molecular Pharmacology and Drug Targeting . Edited by Annette Gilchrist Wiley , Hoboken, NJ . 2010 . xxi + 520 pp. 16 × 24 cm. ISBN 978-0-470-30778-6 . $149.95. Drug Development Perspectives. Considerations, Challenges, and Strategies . Edited by Nuggehally R. Srinivas HNB Publishing , New York, NY . 2010 . x + 326 pp. 16 × 24 cm. ISBN 978-0-9664286-9-8 . $99.75. Chemoinformatics and Computational Chemical Biology . Edited by Jürgen Bajorath Humana Press/Springer Science , New York, NY . 2010 . x + 588 pp. 18.5 × 26 cm. ISBN 978-1-60761-838-6 . $159.00. Functional Molecules from Natural Sources . Edited by Stephen K. Wrigley , Robert Thomas , Colin T. Bedford , and Neville Nicholson Royal Society of Chemistry , Cambridge, U.K. 2011 . x + 233 pp. 16 × 24 cm. ISBN 978-1-84755-259-4 . £109.99.

📂 Article 📅 2011 🏛 American Chemical Society 🌐 English ⚖ 606 KB